ITOC Overview

Pheton Holdings Ltd is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.

Wall Street analysts forecast ITOC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ITOC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

iTonic Holdings Ltd revenue for the last quarter amounts to NaN USD, decreased

iTonic Holdings Ltd. EPS for the last quarter amounts to USD, decreased

iTonic Holdings Ltd (ITOC) has 7 emplpoyees as of May 08 2026.

Today ITOC has the market capitalization of 6.01M USD.